42. For which of the following oral formulations would it be appropriate to use a dedicated counting tray labeled For chemo use only?

Answer: A

Explanation:

Methotrexate is the appropriate oral formulation for using a dedicated counting tray labeled For chemo use only.

Methotrexate is a chemotherapeutic agent that requires special handling due to its toxicity and potential for causing harm. Therefore, it is essential to use a dedicated counting tray specifically labeled for chemotherapy to prevent cross-contamination with other medications.

A) Methotrexate

This option is correct because methotrexate is classified as an antineoplastic agent and poses significant risks if improperly handled. Using a dedicated counting tray labeled for chemotherapy ensures that it is only used for this hazardous medication, thereby minimizing the risk of exposure to pharmacy staff and patients.

B) Metoprolol

Metoprolol is a beta-blocker used primarily for cardiovascular conditions and does not possess the same level of toxicity as chemotherapy agents. Therefore, it does not require a dedicated counting tray labeled for chemotherapy, making this option incorrect.

C) Gabapentin

Gabapentin is an anticonvulsant and neuropathic pain agent that is not classified as a chemotherapy drug. Its handling does not require the same precautions as methotrexate, so a dedicated counting tray for chemo use is unnecessary, rendering this option incorrect.

D) Sumatriptan

Sumatriptan is primarily used for the treatment of migraine headaches and is not part of chemotherapy protocols. Since it does not have the associated risks of chemotherapeutic agents, it does not warrant the use of a dedicated counting tray labeled for chemotherapy, making this option incorrect as well.

Conclusion

Methotrexate is the only medication among the options that necessitates the use of a dedicated counting tray labeled for chemo use, due to its potential toxicity and risk factors associated with chemotherapy handling. The other options, including metoprolol, gabapentin, and sumatriptan, do not require such specific handling, as they are not classified as chemotherapy agents. Thus, methotrexate is the definitive correct answer.